Physiomics (PYC LN)

Analysis

Industrials • United Kingdom

Physiomics is a data-driven consultancy that provides Model-Informed Drug Development (MIDD), Biostatistics, Statistical Programming, and Bioinformatics solutions to biopharmaceutical companies and research institutes. The company utilizes its proprietary Virtual Tumour technology platform to optimize the design of cancer clinical trials and predict the effects of treatments. Physiomics was founded in 2001 and is headquartered in Abingdon, United Kingdom.

Refresh

Exchange Announcement • 14 Oct 2026 13:00

Contract Win and Commercial Opportunities

Exchange Announcement • 13 Oct 2026 13:00

Final Results & Notice of AGM

Exchange Announcement • 10 Sep 2026 13:00

Physiomics Awarded New Contract Wins

Exchange Announcement • 26 Aug 2026 16:00

Holding(s) in Company

Exchange Announcement • 21 Aug 2026 22:12

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00